Some users report less nausea when they take their dose in the evening rather than morning, allowing sleep to occur during the period of peak medication effect
Weakness, exhaustion, constipation, appetite loss, and weight loss are typical symptoms
Signs include itching, rashes, swelling or difficulty breathing
Bell GI, Sanchez-Pescador R, Laybourn PJ, Najarian RC (1983) Exon duplication and divergence in the human preproglucagon gene
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165